Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2015

Derivative Instruments [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

		December 31, 2015		December 31, 2014
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	1,175,000	$	900,000
Denominated in Pounds Sterling	£	550,000	£	350,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	72,000	$	58,000
Denominated in Pounds Sterling	£	60,000	£	40,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	47,000	$	12,000

Schedule of Derivative Instruments Included in Trading Activities [Table Text Block]

		Year Ended
	Location	December 31, 2015		December 31, 2014		December 31, 2013
Gain (loss) on forward exchange contracts recognized in income	Gain (loss) on derivatives, net	$	-	$	1,495	$	(4,470)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		14,474		-		-
Loss (gain) on option exercise(1)	Gain (loss) on derivatives, net		(58,427)		-		-
Gain (loss) on forward exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		298,116		103,140		(28,244)
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.